Lower Urine Tenofovir Concentrations Among Individuals Taking Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate: Implications for Point-of-Care Testing

MLA

Peter L. Anderson, et al. “Lower Urine Tenofovir Concentrations Among Individuals Taking Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate: Implications for Point-of-Care Testing.” Open Forum Infectious Diseases, vol. 8, no. 7, Feb. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....bf64db4a2f343f514cddca8ff92a0854&authtype=sso&custid=ns315887.

APA

Peter L. Anderson, Xin Niu, Tim R. Cressey, Mary Morrow, Hideaki Okochi, Jenna Yager, David V. Glidden, Matthew A Spinelli, Paul K. Drain, Monica Gandhi, Jose R Castillo-Mancilla, Samantha MaWhinney, & Kelly A. Johnson. (2021). Lower Urine Tenofovir Concentrations Among Individuals Taking Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate: Implications for Point-of-Care Testing. Open Forum Infectious Diseases, 8(7).

Chicago

Peter L. Anderson, Xin Niu, Tim R. Cressey, Mary Morrow, Hideaki Okochi, Jenna Yager, David V. Glidden, et al. 2021. “Lower Urine Tenofovir Concentrations Among Individuals Taking Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate: Implications for Point-of-Care Testing.” Open Forum Infectious Diseases 8 (7). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....bf64db4a2f343f514cddca8ff92a0854&authtype=sso&custid=ns315887.